Literature DB >> 27540003

Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2.

Alessandra Matzeu1, Tony M Kerr2, Friedbert Weiss2, Rémi Martin-Fardon2.   

Abstract

Orexin/hypocretin (Orx/Hcrt) projections from the lateral hypothalamus to the paraventricular nucleus of the thalamus (PVT) are implicated in drug addiction. Specifically, the posterior section of the PVT (pPVT) innervates brain structures that modulate motivated behavior. This study investigated the role of pPVT-Orx/Hcrt transmission in cocaine-seeking behavior. Because the effects of Orx/Hcrt are mediated by two Orx/Hcrt receptors (Hcrt-r1 and Hcrt-r2), we examined the extent to which Hcrt-r1 and Hcrt-r2 are involved in Orx/Hcrt-induced cocaine seeking. Male Wistar rats were made cocaine dependent by self-administering cocaine 6 hours/day (long access) for 21 days. After self-administration training, the rats underwent daily extinction training, during which cocaine was withheld. After extinction, the rats were injected into the pPVT with Orx-A/Hcrt-1 (0-2 µg) alone or, using a single dose of 0.5 µg, in combination with an Hcrt-r1 antagonist (SB334867; 0-15 µg) or an Hcrt-r2 antagonist (TCSOX229; 0-15 µg). Orx-A/Hcrt-1 alone reinstated (primed) cocaine seeking. Unexpectedly, coadministration of Orx-A/Hcrt-1 with SB334867 did not have any effects on Orx-A/Hcrt-1-induced reinstatement, whereas when coadministered with Orx-A/Hcrt-1, TCSOX229 prevented cocaine-seeking behavior. These results indicate that Hcrt-r2 in the pPVT mediates the reinstating effect of Orx-A/Hcrt-1 in animals with a history of cocaine dependence and further identify Hcrt-r2 as a possible molecular target that can guide future therapeutic approaches for the prevention of drug-seeking behavior.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27540003      PMCID: PMC5074483          DOI: 10.1124/jpet.116.235945

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  72 in total

1.  Self-administration of psychomotor stimulant drugs: the effects of unlimited access.

Authors:  C E Johanson; R L Balster; K Bonese
Journal:  Pharmacol Biochem Behav       Date:  1976-01       Impact factor: 3.533

2.  Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement.

Authors:  James R Shoblock; Natalie Welty; Leah Aluisio; Ian Fraser; S Timothy Motley; Kirsten Morton; James Palmer; Pascal Bonaventure; Nicholas I Carruthers; Timothy W Lovenberg; Jamin Boggs; Ruggero Galici
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

3.  Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors.

Authors:  B Jupp; E Krstew; G Dezsi; A J Lawrence
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking.

Authors:  Morgan H James; Janine L Charnley; Emily M Levi; Emma Jones; Jiann Wei Yeoh; Doug W Smith; Christopher V Dayas
Journal:  Int J Neuropsychopharmacol       Date:  2011-03-29       Impact factor: 5.176

5.  Patterns of brain activation associated with contextual conditioning to methamphetamine in mice.

Authors:  Justin S Rhodes; Andrey E Ryabinin; John C Crabbe
Journal:  Behav Neurosci       Date:  2005-06       Impact factor: 1.912

6.  Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.

Authors:  Luyi Zhou; Rachel J Smith; Phong H Do; Gary Aston-Jones; Ronald E See
Journal:  Neuropharmacology       Date:  2012-08-07       Impact factor: 5.250

7.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

8.  Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.

Authors:  Yonghui Li; Huiying Wang; Keke Qi; Xiaoyu Chen; Sa Li; Nan Sui; Gilbert J Kirouac
Journal:  Physiol Behav       Date:  2010-10-14

9.  Cocaine- and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour.

Authors:  Morgan H James; Janine L Charnley; Emma Jones; Emily M Levi; Jiann Wei Yeoh; Jamie R Flynn; Douglas W Smith; Christopher V Dayas
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala.

Authors:  Sa Li; Gilbert J Kirouac
Journal:  J Comp Neurol       Date:  2008-01-10       Impact factor: 3.215

View more
  33 in total

Review 1.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

2.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

3.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

Review 4.  Orexin/Hypocretin System: Role in Food and Drug Overconsumption.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Int Rev Neurobiol       Date:  2017-08-08       Impact factor: 3.230

5.  Transient inactivation of the paraventricular nucleus of the thalamus enhances cue-induced reinstatement in goal-trackers, but not sign-trackers.

Authors:  Brittany N Kuhn; Marin S Klumpner; Ignacio R Covelo; Paolo Campus; Shelly B Flagel
Journal:  Psychopharmacology (Berl)       Date:  2017-12-28       Impact factor: 4.530

Review 6.  The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.

Authors:  David E Moorman
Journal:  Psychopharmacology (Berl)       Date:  2018-03-06       Impact factor: 4.530

7.  phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol-preferring from genetically heterogenous rats.

Authors:  A Bifone; A Gozzi; A Cippitelli; A Matzeu; E Domi; H Li; G Scuppa; N Cannella; M Ubaldi; F Weiss; R Ciccocioppo
Journal:  Addict Biol       Date:  2018-10-17       Impact factor: 4.280

Review 8.  The thalamus in drug addiction: from rodents to humans.

Authors:  Anna S Huang; Jameson A Mitchell; Suzanne N Haber; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

Review 9.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

10.  The lateral hypothalamus and orexinergic transmission in the paraventricular thalamus promote the attribution of incentive salience to reward-associated cues.

Authors:  Joshua L Haight; Paolo Campus; Cristina E Maria-Rios; Allison M Johnson; Marin S Klumpner; Brittany N Kuhn; Ignacio R Covelo; Jonathan D Morrow; Shelly B Flagel
Journal:  Psychopharmacology (Berl)       Date:  2020-08-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.